Start here if you're new
what it is
Gildan makes basic shirts, underwear, and socks for printers and stores.
how it gets paid
Last year Gildan Activewear made $3.6B in revenue. T-shirts and blanks was the main engine at $1.50B, or 42% of sales.
why it's growing
Annual revenue grew 10.7% on the ~$3.6B total above. In the September quarter, net sales rose about 2% vs. prior year while activewear grew about 5%—quarterly cadence can be slower than the full-year headline.
what just happened
Gildan posted about $911M in quarterly sales (September quarter) and beat EPS by 2.13%—that quarter sits inside the ~$3.6B annual revenue total.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
25/100 earnings predictability — expect surprises
18.3x trailing p/e — priced about right
1.6% dividend yield — cash in your pocket every quarter
15.0% return on capital — respectable for a basics manufacturer
xvary composite: 58/100 — below average
What they do
Gildan makes basic shirts, underwear, and socks for printers and stores.
Gildan makes its own yarn, fabric, sewing, and distribution. That means your shirt moves through one factory chain, not a line of middlemen. Activewear was 87% of 2024 sales, so one boring product family keeps doing most of the work.
How they make money
$3.6B
annual revenue · their business grew +10.7% last year
T-shirts and blanks
$1.50B
+4.0%
Sport shirts
$0.70B
+3.0%
Fleece and sweats
$0.90B
+2.0%
Underwear
$0.30B
0.0%
Hosiery
$0.20B
0.0%
The products that matter
blank basics manufacturing
blank t-shirts
core of a $3.6B business
these plain tees sit at the heart of the replenishment model. they feed a $3.6B revenue base where buyers care more about cost and availability than fashion cycles.
volume driver
fleece and basics
sweatshirts and fleece
13.5% net margin backdrop
this category matters because basics with repeat demand help support the company's 13.5% net margin. in human-speak: boring products can still be good business when the replenishment cycle stays intact.
repeat demand
deal-driven expansion
hanesbrands transaction
$2B deal scrutiny
this is not a product line. it's the strategic bet hanging over the stock. the antitrust process around the roughly $2B transaction matters more to the next chapter than another quarter of routine basics demand.
swing factor
Key numbers
$4.50
FY2026 EPS
That is the profit estimate per share. Higher earnings support the stock without needing a miracle.
$7B
FY2026 revenue est.
Forward estimate—not the ~$3.6B trailing annual revenue in the segment table. Compare like periods.
22.5%
op margin
That is the share of sales left after running the business. Clothes are ordinary. A 22.5% margin is not.
15.0%
return on capital
That is how hard the business makes each dollar work. You want the machine to earn more than its own cost.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 65 / 100
- long-term debt $1.3B (12% of capital)
- net profit margin 13.5% — keeps 14 cents of every dollar in revenue
- return on equity 27% — $0.27 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in GIL 3 years ago → it's now worth $24,100.
The index would have given you $14,770.
source: institutional data · total return
What just happened
beat estimates
Gildan posted ~$911M in quarterly sales and beat EPS by 2.13%.
Revenue rose 2% vs. prior year. Activewear grew 5%, while international sales fell 6% and gross margin moved to near 34%. News copy rounds EPS to $1.00; some data rows show ~$0.96 before rounding—same quarter, not two different profits.
$911M
revenue (Q)
$1.00
eps (Q · rounded)
34.0%
gross margin (Q)
EPS surprise
The 2.13% EPS beat mattered because it came with near-34% gross margin, not because of a one-off trick.
-
gildan activewear’s profitability has been improving despite uneven markets.
-
net sales in the september quarter reached $911 million, up 2% vs. prior year, driven by activewear growth of 5% on higher pricing and favorable mix, while hosiery continues to decline following the expiration of a key license.
-
meantime, the gross margin expanded to near 34%, a 250 basis point rise, benefiting from lower manufacturing costs and pricing actions largely offsetting tariff impacts.
-
the operating backdrop is uneven, with international sales falling off by 6%, and tariffdriven uncertainties and cautious inventory activity seen affecting distribution channels.
-
still, the bottom line made an 18% advance to $1.00 per share, reflecting strong operating leverage and boosted by share buybacks.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is antitrust review of the proposed hanesbrands transaction. after that, you are dealing with estimate quality, trade-policy noise, and the chance that a basics business gets valued like a cleaner story than it is.
med
the hanesbrands deal is still a real gating item
multiple october 2025 items referenced filings and a refiling with U.S. antitrust authorities around the roughly $2B transaction. when a deal needs a second trip through the process, approval timing stops being a footnote.
stated exposure in the source set: $540M–$900M of revenue at risk if the transaction logic or timing breaks.
med
estimate quality is weak for a business people think is predictable
earnings predictability sits at 25/100. basics apparel sounds simple. the score says the numbers are less smooth than the story. that matters more when the stock trades near the top of its 52-week range.
a re-rating does not need a collapse. it only needs another quarter that reminds investors this is not a utility.
med
trade-policy exposure can pressure the margin story
the october 13, 2025 source item on potential import-related pressure was thin, so we are keeping the claim narrow. still, apparel sourcing and tariffs have a way of showing up in gross margin before they show up in headlines.
if costs move the wrong way, a 13.5% net margin stops looking comfortably boring.
med
valuation discipline is part of the risk now
the stock sits at $64.21 against a near-term target midpoint of $59. in human-speak: you are already above the center of the current target range while the big strategic question is still unresolved.
that setup limits your margin for error even if the core business stays fine.
the combined picture is not existential. it is simpler than that: the operating business looks stable, but the next move in the stock depends on deal clarity and whether current expectations are already too generous.
source: institutional data · regulatory filings · risk analysis
Pay attention to
deal timeline
watch the next antitrust milestone on hanesbrands
this is the event that can clear the air or extend the discount. the deal process is now part of the investment case, not side noise.
margin
see if the 13.5% net margin holds up
basic apparel works when boring stays profitable. if margin slips, the market will stop treating this like a clean operator.
estimates
check whether the $7B revenue estimate gets explained or cut
that figure sits far above the current $3.6B revenue base. you want a clear bridge, not a mystery number.
ownership
follow whether institutional buying keeps showing up
net buying for two quarters is supportive. if that flips while the stock sits near the top of its range, the tone changes fast.
Analyst rankings
earnings predictability
25 / 100
earnings are harder to model than the product lineup suggests. in human-speak, analysts do not see this as a smooth quarter-after-quarter story.
risk rank
3
risk rank 3 means the balance sheet and business profile look middle-of-the-pack on safety. not fragile. not a bunker.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 201 buyers vs. 127 sellers in 3q2025. total institutional holdings: 0.1B shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$42
$76
$64
current price
$59
target midpoint · ~8% below current · 3-5yr range top: $76 per bar endpoints (above)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive